Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Benjamin L Palleiko, director, officer

Transaction date: Feb. 21, 2026

Reporting date: Feb. 24, 2026

Average share price: -11.81880078692494

Sold 13216.0 shares for 156197.27